Standard Biotools | FLDM - Trade Creditors


Standard Biotools reported $7.33M in Trade Creditors for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 556.96M
Cash and Equivalent USD 158.62M
Cost of Sales USD 11.13M
Current Assets USD 506.04M
Current Liabilities USD 98.02M
Debt USD 28.62M
EBIT USD -18.27M
EBITDA USD -14.28M
Employees 534
EPS Earnings Per Share USD -0.05
Equity Capital and Reserves USD 424.54M
Gross Profit on Sales USD 10.63M
Interest Expense on Debt USD 9K
Interest Income USD 2.46M
Loan Capital USD 299K
Market Capitalization USD 483.9M
Net Income USD -33.46M
Operating Expenses USD 45.46M
Operating Profit USD -23.7M
Ordinary Share Capital USD 381.69M
Pre-Tax Profit USD -18.28M
Sales Revenues USD 21.76M
Selling and Administration Expenses USD 28.1M
Stock USD 24.17M
Trade Creditors USD 7.33M
Trade Debtors USD 14.61M

Trade Creditors Change Date
Agilent USD 530M 13M Jul/2025
Becton, Dickinson and Co. USD 6.35B 4.45B Jun/2025
Bio-Rad Laboratories USD 139.3M 1.4M Jun/2025
Bruker USD 243M 1.6M Jun/2025
Danaher USD 1.72B 3M Jun/2025
Illumina USD 200M 7M Jun/2025
Myriad Genetics USD 28.1M 4.2M Mar/2025
Nikon Corporation JPY 78.9B 3.3B Jun/2025
Revvity USD 178.15M 65K Jun/2025
Roche Holding CHF 4.35B 828M Dec/2024
Sony JPY 2.05T 49.89B Jun/2025
Standard Biotools USD 7.33M 4.95M Jun/2025
Thermo Fisher Scientific USD 3.05B 30M Mar/2025
Waters USD 97.91M 4.14M Jun/2025